Differential Actions of Peripheral Corticotropin-Releasing Factor (CRF), Urocortin II, and Urocortin III on Gastric Emptying and Colonic Transit in Mice: Role of CRF Receptor Subtypes 1 and 2
- 1 May 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 301 (2) , 611-617
- https://doi.org/10.1124/jpet.301.2.611
Abstract
ATP-binding cassette (ABC) transporters are a large family of proteins whose role is to translocate various substances across biological membranes. They include the Tangier disease protein ABC1, sulfonylurea receptors (SUR), multidrug resistance protein (MDR), and cystic fibrosis transmembrane regulator (CFTR). In the current study, we investigated the involvement of ABC transporters in the regulation of lipopolysaccharide (LPS) and/or interferon (IFN)-γ-induced interleukin (IL)-12 p40 and tumor necrosis factor (TNF)-α production, nitric oxide formation, as well as major histocompatibility complex II up-regulation in macrophages. The general ABC transporter inhibitor glibenclamide suppressed both IL-12 p40 and nitric oxide production. However, glibenclamide failed to affect the production of TNF-α. The selective ABC1 inhibitors 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid and sulfobromophthalein mimicked the suppressive effect of glibenclamide on IL-12 p40 production. On the other hand, both the MDR inhibitor verapamil and CFTR blocker 2,2′-iminodibenzoic acid failed to suppress the production of IL-12 p40. Furthermore, selective inhibitors and activators of SURs were without effect. In agreement with the pharmacological data, macrophages expressed mRNA for ABC1, but not SURs or CFTR. Intracellular levels of IL-12 p40 were decreased by glibenclamide, suggesting that glibenclamide does not affect IL-12 p40 secretion. The effect of glibenclamide did not involve an interference with the activation of the p38 and p42/44 mitogen-activated protein kinases or c-Jun kinase. Glibenclamide also suppressed IFN-γ-induced up-regulation of major histocompatibility complex II. Taken together, our results indicate that ABC proteins regulate LPS and/or IFN-γ-induced macrophage activation.Keywords
This publication has 32 references indexed in Scilit:
- A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: Implications for the design of agonists and antagonistsProceedings of the National Academy of Sciences, 2001
- Pharmacological and chemical properties of astressin, antisauvagine-30 and α-helCRF: significance for behavioral experimentsNeuropharmacology, 2001
- Therapeutic potential of CRF receptor antagonists: a gut-brain perspectiveExpert Opinion on Investigational Drugs, 2001
- mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissuesJournal of Molecular Endocrinology, 2000
- Urocortin reduces food intake and gastric emptying in lean and ob/ob obese miceGastroenterology, 1999
- Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndromeGut, 1998
- Cloning and characterization of human urocortin.Endocrinology, 1996
- Design and Synthesis of a Series of Non-Peptide High-Affinity Human Corticotropin-Releasing Factor1 Receptor AntagonistsJournal of Medicinal Chemistry, 1996
- Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.Proceedings of the National Academy of Sciences, 1995
- Corticotropin-releasing hormone excites myenteric neurons in the guinea-pig small intestineEuropean Journal of Pharmacology, 1992